About Cytoki

Cytoki Leadership
Cytoki’s team of experienced executives combine deep expertise in IL-22 biology, lipidation technology and drug development. They are uniquely positioned to leverage the potential of IL-22 as a new treatment paradigm for serious diseases involving epithelial injury.

Our team

Rasmus Jorgensen, PhD
CEO

Anne Louise Kjølbye, PhD, MBA
Chief Development Officer

Martijn van de Bunt, MD, DPhil
Vice President of Research

Jens Chr. Norrild, PhD
Vice President of CMC

Karsten Skydsgaard, DVM, E*MBA
Head of Non-Clinical Development
Our board

Christian Elling
Chairperson and Managing Partner, Lundbeckfonden BioCapital

Karen Wagner
Managing Partner, Ysios Capital

Dani Bach
Partner, +ND Capital

Amanda Chaperot
Partner, Seventure Partners